Share on PinterestNew research suggests that there may be more than 10.5 million people in the United States living with ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

New research indicates that 1 hour of moderate exercise per week can help prevent atrial fibrillation (AFib). While a small ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...

After two years of treatment to get Afib under control, Thosani enrolled in the REACT-AF study, and says he has been off his ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024. Recent Highlights: Third quarter revenue from Continuing Operations ...

MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...

The findings build on prior evidence suggesting that exercise, even at minimum recommended levels, is protective against atrial fibrillation (AFib), the most common form of heart arrhythmia.